A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
Clinical trial NCT04109508 · COMPLETED
Trial details
- NCT number
- NCT04109508
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2020-12-24
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.